Artigos Publicados
Sodium Bicarbonate for Critically Ill Adults with Metabolic Acidosis and Shock (SODa-BIC)
Effects of dapagliflozin on urinary output, fluid balance, and biochemistry (post-hoc DEFENDER)
COVID-19-related hyperglycemia is associated with infection of hepatocytes and gluconeogenesis
Typical phenotypes of patients with acute respiratory failure with and without COVID-19
Dapagliflozin in Acute Cardiovascular Conditions (DEFENDER)
Protocol summary and statistical analysis plan for the SODa-BIC trial
Dapagliflozin in patients with critical illness: rationale and design of DEFENDER
Dapagliflozin in patients with critical illness: rationale and design of DEFENDER
Building neurocritical care education in Brazil: from recognition to action
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction (DEFENDER)
Epidemiology and disease burden of patients requiring neurocritical care (Brazilian multicentre cohort)
Accuracy of the persistent AKI risk index in predicting acute kidney injury
Safety and outcomes of dapagliflozin initiation in critically ill patients with acute kidney injury (DEFENDER)
Lactate and base excess as markers of hypoperfusion and mortality in traumatic hemorrhagic shock
Diagnostic accuracy of clinical and radiological criteria for COVID-19 screening (RT-PCR)
Dysglycemias in patients admitted to ICUs with severe acute respiratory syndrome (COVID-19 vs other)
Dysglycemias in ICUs
with severe acute respiratory syndrome - a cohort
study
Dapagliflozin for Critically Ill Patients With Acute Organ Dysfunction: The DEFENDER Randomized Clinical Trial. (2024)
Typical phenotypes of patients with acute respiratory failure with and without COVID-19 and their relationship with outcomes: a cohort study. (2023)
Chloroquine/
Hydroxychloroquine in severe COVID-19: A Clinical Trial
Dapagliflozin in patients with critical illness: rationale and design of the DEFENDER study. (2023)
Diagnostic accuracy of a set of clinical and radiological criteria for screening of COVID-19 using RT-PCR as the reference standard.(2023)
Parkinson’s Disease in ICU: A Cohort Study
Lactate and base excess (BE) as markers of hypoperfusion and mortality in traumatic hemorrhagic shock in patients undergoing Damage Control: a historical cohort. (2024)
Accuracy of the persistent AKI risk index in predicting acute kidney injury in patients admitted to the intensive care unit for acute respiratory failure. (2023)
ICU mortality in TBI patients: A Cohort Study
Epidemiology and disease burden of patients requiring neurocritical care: a Brazilian multicentre cohort study. (2023)
WITHDRAWN: Recomendações para Ressuscitação Cardiopulmonar (RCP) de pacientes com diagnóstico ou suspeitos de COVID-19 (2020).